KBC Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57K | Hold |
6,093
| – | – | ﹤0.01% | 1546 |
|
|
2025
Q1 | $43K | Hold |
6,093
| – | – | ﹤0.01% | 1818 |
|
|
2024
Q4 | $71K | Buy |
6,093
+2,340
| +62% | +$27.3K | ﹤0.01% | 1727 |
|
|
2024
Q3 | $77K | Buy |
3,753
+1,020
| +37% | +$20.9K | ﹤0.01% | 1459 |
|
|
2024
Q2 | $61K | Buy |
2,733
+940
| +52% | +$21K | ﹤0.01% | 1499 |
|
|
2024
Q1 | $49K | Hold |
1,793
| – | – | ﹤0.01% | 1572 |
|
|
2023
Q4 | $55K | Hold |
1,793
| – | – | ﹤0.01% | 1461 |
|
|
2023
Q3 | $57K | Buy |
+1,793
| New | +$57K | ﹤0.01% | 1337 |
|
|
2020
Q4 | – | Sell |
-2,040
| Closed | -$40K | – | 1282 |
|
|
2020
Q3 | $40K | Hold |
2,040
| – | – | ﹤0.01% | 1215 |
|
|
2020
Q2 | $42K | Buy |
2,040
+1,020
| +100% | +$21K | ﹤0.01% | 1249 |
|
|
2020
Q1 | $12K | Hold |
1,020
| – | – | ﹤0.01% | 1266 |
|
|
2019
Q4 | $15K | Sell |
1,020
-2,940
| -74% | -$43.2K | ﹤0.01% | 1469 |
|
|
2019
Q3 | $53K | Buy |
3,960
+3,440
| +662% | +$46K | ﹤0.01% | 1384 |
|
|
2019
Q2 | $9K | Hold |
520
| – | – | ﹤0.01% | 1438 |
|
|
2019
Q1 | $9K | Buy |
520
+260
| +100% | +$4.5K | ﹤0.01% | 1397 |
|
|
2018
Q4 | $4K | Sell |
260
-265
| -50% | -$4.08K | ﹤0.01% | 1305 |
|
|
2018
Q3 | $14K | Hold |
525
| – | – | ﹤0.01% | 1375 |
|
|
2018
Q2 | $14K | Hold |
525
| – | – | ﹤0.01% | 1274 |
|
|
2018
Q1 | $11K | Hold |
525
| – | – | ﹤0.01% | 1262 |
|
|
2017
Q4 | $10K | Buy |
+525
| New | +$10K | ﹤0.01% | 1247 |
|